BioSpace News Archive

PHARMASEAL Launches Second Major Release of EngilityÔ CTMS

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its EngilityÔ CTMS platform.

July 8, 2019
·
2 min read
Drug Development

Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab

Prestige BioPharma announced positive results from a Phase I clinical trial evaluating the pharmacokinetics, safety and immunogenicity of biosimilar candidate HD204 to Avastin.

July 8, 2019
·
3 min read
Policy

Trump Plans New ‘Favored Nations Clause’ to Tie Drug Prices to the Cost Other Nations Pay

The executive order will demand that drugs purchased by the federal government will not cost more than the lowest price paid by other nations.

July 8, 2019
·
2 min read
·
Alex Keown
Drug Development

Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival in patients with BRAF-mutated metastatic colorectal cancer, according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

July 8, 2019
·
5 min read
Drug Development

Array BioPharma’s Triple-Drug Combo Could be Gamechanger for Colorectal Cancer

Median progression-free survival for patients receiving Braftovi Triplet was 4.3 months compared to 1.5 months.

July 8, 2019
·
2 min read
·
Mark Terry
Ascension Healthcare Announces Attendance at ISTH 2019

Ascension Healthcare plc announces it will be attending the 27th International Society of Thrombosis and Haemostasis Congress, taking place in Melbourne, Australia, from Saturday 6th July to Wednesday 10th July.

July 8, 2019
·
1 min read
Business

Eisai Enters Into Collaboration Research Agreement With University of Dundee on Targeted Protein Degradation Toward Cancer Drug Discovery

Eisai Co.,Ltd. has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Targeting Chimeras (PROTACs)(1) toward drug discovery in oncology area.

July 8, 2019
·
3 min read
Business

Immatics Appoints Harpreet Singh as Chief Executive Officer

Immatics Biotechnologies GmbH announced that Harpreet Singh has been appointed the Company’s Chief Executive Officer.

July 8, 2019
·
4 min read
Business

Domain Therapeutics appoints Xavier Leroy as chief technology officer

Drug discovery expert will be responsible for developing Domain’s platforms and driving technology-based projects to support Domain’s development and growth

July 8, 2019
·
3 min read
Business

Lung Ambition Alliance launches with goal to double five-year survival in lung cancer by 2025

Collaboration prioritizes scientific innovation and social change to one day eliminate lung cancer as a cause of death

July 8, 2019
·
7 min read